Elixinol Wellness (ASX:EXL) Pretax Margin %: -37.44% (As of Dec. 2025)


What is Elixinol Wellness Pretax Margin %?

Elixinol Wellness ASX:EXL Pretax Margin % is -37.44% as of Dec. 2025. The stock has 7 warning signs investors should review. Among 955 Drug Manufacturers companies, Elixinol Wellness ranks worse than 85.03% on this metric.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Elixinol Wellness's Pre-Tax Income for the six months ended in Dec. 2025 was A$-2.94 Mil. Elixinol Wellness's Revenue for the six months ended in Dec. 2025 was A$7.86 Mil. Therefore, Elixinol Wellness's pretax margin for the quarter that ended in Dec. 2025 was -37.44%.

The historical rank and industry rank for Elixinol Wellness's Pretax Margin % or its related term are showing as below:

ASX:EXL' s Pretax Margin % Range Over the Past 10 Years
Min: -668.07   Med: -120.28   Max: -1.34
Current: -38.94


ASX:EXL's Pretax Margin % is ranked worse than
85.03% of 955 companies
in the Drug Manufacturers industry
Industry Median: 7.28 vs ASX:EXL: -38.94

Elixinol Wellness  (ASX:EXL) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Elixinol Wellness Pretax Margin % Related Terms


Elixinol Wellness Pretax Margin % Historical Data

* Premium members only.

The historical data trend for Elixinol Wellness's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Elixinol Wellness Pretax Margin % Chart

Elixinol Wellness Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Pretax Margin %
Get a 7-Day Free Trial -183.02 -149.81 -90.75 -35.51 -38.94

Elixinol Wellness Semi-Annual Data
Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -85.38 -40.68 -31.23 -40.47 -37.44

ASX:EXL vs ZTS, UTHR, VTRS: Pretax Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Elixinol Wellness's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Elixinol Wellness Pretax Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Elixinol Wellness's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Elixinol Wellness's Pretax Margin % falls into.



Elixinol Wellness Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Elixinol Wellness's Pretax Margin for the fiscal year that ended in Dec. 2025 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-6.035/15.5
=-38.94 %

Elixinol Wellness's Pretax Margin for the quarter that ended in Dec. 2025 is calculated as

Pretax Margin=Pre-Tax Income (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-2.942/7.858
=-37.44 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Pretax Margin % →
What does a Pretax Margin % of -37.44% mean?
Elixinol Wellness (ASX:EXL) has a Pretax Margin % of -37.44% as of Dec. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Elixinol Wellness and its competitors. According to the industry distribution chart, Elixinol Wellness ranks #812 out of 955 companies in the Drug Manufacturers industry, placing it in the top 85%.
Is Elixinol Wellness' Pretax Margin % too high?
Elixinol Wellness' current Pretax Margin % is -37.44%. Based on the distribution chart, Elixinol Wellness ranks #812 out of 955 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Elixinol Wellness' Pretax Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Elixinol Wellness ranks #812 out of 955 companies for Pretax Margin %. This places Elixinol Wellness in the lower half of its industry. The industry median Pretax Margin % is 7.28. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Drug Manufacturers company?
The median Pretax Margin % among Drug Manufacturers companies is 7.28, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Elixinol Wellness and its competitors. For the Drug Manufacturers industry, the median Pretax Margin % is 7.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Elixinol Wellness's current Pretax Margin % is -37.44%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elixinol Wellness stock overvalued right now?
Based on GuruFocus' analysis, Elixinol Wellness (ASX:EXL) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.02, compared to a current price of A$0.01 — trading 70% below its estimated fair value. The current Pretax Margin % is -37.44%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Elixinol Wellness (ASX:EXL), the current Pretax Margin % is -37.44% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Elixinol Wellness Business Description

Other Exchanges ELLXF:USAE8M:Germany
Address 51 - 53 Riversdale Road, Newtown, VIC, AUS, 3220
Elixinol Wellness Ltd is engaged in the hemp industry, innovating, marketing, and selling hemp-derived nutraceutical, cosmetic, and food products. It operates in the three operating segments of the Americas, Australia, Rest of the World regions of which key revenue is derived from the Australia segment. The Australia segment includes the results from operations of Elixinol Wellness (Byron Bay) Pty Ltd and The Sustainable Nutrition Group Pty Ltd and its subsidiaries. It derives maximum revenue from Australia.